Brighton Park Capital has acquired a majority stake in Franklin, Tennessee-based Relatient, a patient engagement vendor. No financial terms were disclosed. Spurrier Capital Partners served as financial adviser to Relatient on the deal.
NASHVILLE, TN. (November 14, 2019) — Relatient, the leading customer-rated patient engagement vendor, today announced that Brighton Park Capital has acquired a majority stake in the company as well as invested a significant amount of growth capital. The agreement provides for a significant new equity capital investment and positions Relatient for continued leadership and growth in the patient engagement ecosystem.
“We are thrilled to be working with Brighton Park Capital. They believe, like we do, that Relatient is uniquely positioned to continue transforming patient engagement,” said Michele Perry, Chief Executive Officer, Relatient. “With this investment, we will be able to execute faster on our growth strategy and add more resources toward innovating better experiences for our customers and their patients across our platform and in healthcare.”
Through the recapitalization, Brighton Park Capital is acquiring a majority interest in Relatient. Sam Kentor, a Principal at Brighton Park Capital, commented, “We are delighted to partner with the management team at Relatient. Under their stewardship, the company has become a leader in digital outreach and mobile access in the rapidly growing patient engagement space. We are excited to invest in the preeminent industry platform and support Relatient to provide best-in-class services to their customers and partners.”
Eric A. Spiegel, a Senior Advisor to Brighton Park Capital and Former President and CEO of Siemens USA, will join as Chairman of Relatient’s board. The company will use the proceeds from its recapitalization to hire additional employees, fund continued development of its patient engagement platform, and speed customer growth.
“What excites us about Relatient is their relentless focus to enhance the patient experience with innovative technology for healthcare organizations that also drives better outcomes,” said Eric A. Spiegel.
This announcement comes just a week after Relatient’s inclusion in:
The KLAS Patient Engagement Ecosystem 2019 Report (released November 7, 2019). In this report, Relatient is listed with an overall performance score of 93.5 — the highest score of 17 vendors listed in the report.
Deloitte’s 2019 Technology Fast 500 Awards (released November 7, 2019). Relatient is included for the second consecutive year. Making the list at #398 in 2019.
Spurrier Capital Partners served as the exclusive financial advisor to Relatient. Cooley LLP served as legal advisor to Relatient. Kirkland & Ellis LLP served as legal advisor to Brighton Park Capital.
Relatient is an industry recognized and award-winning, SaaS-based patient engagement company that improves patient and provider communications for increased patient satisfaction and improved productivity. Relatient has engaged more than 25 million patients on behalf of U.S. providers, medical practices, hospitals, and health systems and annually delivers 120 million patient messages. Relatient’s platform integrates with more than 85 practice management and electronic health databases to stop the phone tag, eliminate bottlenecks, reduce no-shows, drive appointments, increase online reviews, get patient feedback, and speed patient payments, all while supporting health and care quality initiatives. Visit www.relatient.net, call 866-473-8160, or follow Relatient on Facebook, Twitter, and LinkedIn.
About Brighton Park Capital
Brighton Park Capital is a Greenwich, CT-based investment firm that specializes in software, information services, technology-enabled services, and healthcare. The firm seeks to invest in companies that provide highly innovative solutions and to partner with great management teams and bring purpose built value-add capabilities that match the unique requirements of its companies. For more information about Brighton Park Capital, please visit www.brightonparkcap.com.